Augmenting antidepressants with folate: A clinical perspective

Journal of Clinical Psychiatry

Volumn 68, Issue SUPPL. 10, 2007, Pages 4-7

  Fava, Maurizio ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 METHYLTETRAHYDROFOLIC ACID; ANTIDEPRESSANT AGENT; CEREFOLIN; DEPLIN; ESZOPICLONE; FLUOXETINE; FOLIC ACID; FOLINIC ACID; LITHIUM CARBONATE; METHYLFOLATE; PLACEBO; PSYCHOTROPIC AGENT; UNCLASSIFIED DRUG;

ABSENCE OF SIDE EFFECTS; ADJUVANT THERAPY; ALCOHOLISM; BLOOD BRAIN BARRIER; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DNA POLYMORPHISM; DRUG EFFICACY; DRUG MEGADOSE; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FOLIC ACID BLOOD LEVEL; FOLIC ACID DEFICIENCY; HAMILTON SCALE; HUMAN; HYPOTENSION; MAJOR DEPRESSION; MONOTHERAPY; PRIORITY JOURNAL; REVIEW; UNSPECIFIED SIDE EFFECT;

ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER, MAJOR; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; FOLIC ACID; HUMANS; REMISSION INDUCTION;

EID: 34848816189     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. Nierenberg AA, Dececco LM. Definition of antidepressant treatment response, remission, nonresponse, partial response, and other relevant outcomes: a focus on treatment-resistant depression. J Clin Psychiatry 2001;62(suppl 16):5-9
2. Fava M, Davidson KG. Definition and epidemiology of treatment-resistant depression. Psychiatr Clin North Am 1996;19:179-200
3. Nierenberg AA, Keefe BR, Leslie VC, et al. Residual symptoms in depressed patients who respond acutely to fluoxetine. J Clin Psychiatry 1999;60:221-225
4. Fava M, Graves LM, Benazzi F, et al. A cross-sectional study of the prevalence of cognitive and physical symptoms during long-term antidepressant treatment. J Clin Psychiatry 2006;67:1754-1758
5. 12 and folate serum levels in newly admitted psychiatric patients. Clin Nutr 2006;25:60-67
6. 12, and homocysteine levels in major depressive disorder and the timing of improvement with fluoxetine. Int J Neuropsychopharmacol 2005;8:523-528
7. Tolmunen T, Voutilainen S, Hintikka J, et al. Dietary folate and depressive symptoms are associated in middle-aged Finnish men. J Nutr 2003;133:3233-3236
8. 12, and homocysteine in major depressive disorder, pt 1: predictors of clinical response in fluoxetine-resistant depression. J Clin Psychiatry 2004;65:1090-1095
9. Neuhouser ML, Beresford SA. Folic acid: are current fortification levels adequate? Nutrition 2001;17:868-872
10. Kim YI. Does a high folate intake increase the risk of breast cancer? Nutr Rev 2006;64:468-475
11. Kim YI. Folate and colorectal cancer: an evidence-based critical review. Mol Nutr Food Res 2007;51:267-292
12. Guaraldi GP, Fava M, Mazzi F, et al. An open trial of methyltetrahydrofolate in elderly depressed patients. Ann Clin Psychiatry 1993;5:101-105
13. Di Palma C, Urani R, Agricola R, et al. Is methylfolate effective in relieving major depression in chronic alcoholics? a hypothesis of treatment. Curr Ther Res 1994;55:559-567
14. Glória L, Cravo M, Camillo ME, et al. Nutritional deficiencies in chronic alcoholics: relation to dietary intake and alcohol consumption. Am J Gastroenterol 1997;92:485-489
15. Passeri M, Cucinotta D, Abate G, et al. Oral 5′- methyltetrahydrofolic acid in senile organic mental disorders with depression: results of a double-blind multicenter study. Aging (Milano) 1993;5:63-71
16. Iosifescu DV, Nierenberg AA, Alpert JE, et al. The impact of medical comorbidity on acute treatment in major depressive disorder. Am J Psychiatry 2003;160:2122-2127
17. Iosifescu DV, Bankier B, Fava M. Impact of medical comorbid disease on antidepressant treatment of major depressive disorder. Curr Psychiatry Rep 2004;6:193-201
18. Iosifescu DV, Nierenberg AA, Alpert JE, et al. Comorbid medical illness and relapse of major depressive disorder in the continuation phase of treatment. Psychosomatics 2004;45:419-425
19. Hartman M, van Ede A, Severens JL, et al. Economic evaluation of folate supplementation during methotrexate treatment in rheumatoid arthritis. J Rheumatol 2004;31:902-908
20. Golbahar J, Aminzadeh MA, Sharifkazemi MB, et al. Association of red blood cell 5-methyltetrahydrofolate and severity of coronary artery disease: a cross-sectional study from Shiraz, southern Iran. Heart Vessels 2005;20:203-206
21. 12 in patients with type 2 diabetes mellitis. J Diabetes Complications 2007;21:118-123
22. 6 rapidly normalize endothelial dysfunction in children with type 1 diabetes mellitus. Pediatrics 2006;118:242-253
23. Bazzano LA, Reynolds K, Holder KN, et al. Effect of folic acid supplementation on risk of cardiovascular diseases: a meta-analysis of randomized controlled trials. JAMA 2006;296:2720-2726
24. Flight I, Clifton P. Cereal grains and legumes in the prevention of coronary heart disease and stroke: a review of the literature. Eur J Clin Nutr 2006;60:1145-1159
25. Ignarro LJ, Balestrieri ML, Napoli C. Nutrition, physical activity, and cardiovascular disease: an update. Cardiovasc Res 2007;73:326-340
26. Mischoulon D, Raab MF. The role of folate in depression and dementia. J Clin Psychiatry 2007;68(suppl 10):28-33
27. Trivedi MH, Rush AJ, Wisniewski SR, et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry 2006;163:28-40
28. Fava M, McCall WV, Krystal A, et al. Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder. Biol Psychiatry 2006;59:1052-1060
29. Fava M, Rush AJ. Current status of augmentation and combination treatments for major depressive disorder: a literature review and a proposal for a novel approach to improve practice. Psychother Psychosom 2006;75:139-153
30. Coppen A, Bailey J. Enhancement of the antidepressant action of fluoxetine by folic acid: a randomized, placebo controlled trial. J Affect Disord 2000;60:121-130
31. Kelly CB, McDonnell AP, Johnston TG, et al. The MTHFR C677T polymorphism is associated with depressive episodes in patients from Northern Ireland. J Psychopharmacol 2004;18:567-571
32. Godfrey PSA, Toone BK, Carney MWP, et al. Enhancement of recovery from psychiatric illness by methylfolate. Lancet 1990;336:392-395
33. Alpert JE, Mischoulon D, Rubenstein GE, et al. Folinic acid (leucovorin) as an adjunctive treatment for SSRI-refractory depression. Ann Clin Psychiatry 2002;14:33-38
34. Coppen A, Chaudhry SSC. Folic acid enhances lithium prophylaxis. J Affect Dis 1986;10:9-13